Cavernous angioma pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 23: Line 23:
==Pathophysiology==
==Pathophysiology==


In up to 30% there is a coincidence of CCM with a venous angioma, also known as a developmental venous anomaly (DVA).  These lesions appear either as enhancing linear blood vessels or [[caput medusae]], a radial orientation of small vessels that resemble the hair of Medusa from Greek mythology.  These lesions are thought to represent developmental anomalies of normal venous drainage.  These lesions should not be removed, as reports of venous infarcts have been reported.  When found in association with a CCM that needs resection, great care should be taken not to disrupt the angioma.
In up to 30% there is a coincidence of [[cerebral cavernous malformation]] (CCM0 with a [[venous angioma]], also known as a [[developmental venous anomaly]] (DVA).  These [[lesions]] appear either as enhancing linear [[blood vessels]] or [[caput medusae]], a radial orientation of small [[vessels]] that resemble the hair of Medusa from Greek mythology.  These lesions are thought to represent [[developmental anomalies]] of normal [[venous]] drainage.  These lesions should not be removed, as reports of [[venous]] [[infarcts]] have been reported.  When found in association with a CCM that needs [[resection]], great care should be taken not to disrupt the [[angioma]].


'''Left Orbital Cavernous Hemangioma'''
'''Left [[Orbital]] [[Cavernous Hemangioma]]'''
<gallery>
<gallery>
File:Orbital-hemangioma-001.jpg
File:Orbital-hemangioma-001.jpg
Line 31: Line 31:
</gallery>
</gallery>


Frontal and temporal lobes are the most common sites of occurrence, and 80-90% of the lesions are supratentorial.
[[Frontal]] and [[temporal lobes]] are the most common sites of occurrence, and 80-90% of the lesions are [[supratentorial]].


CCM can also be subdivided into two, according to its pattern of occurrence: <ref name="pmid28387823">{{cite journal| author=Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B | display-authors=etal| title=Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. | journal=Neurosurgery | year= 2017 | volume= 80 | issue= 5 | pages= 665-680 | pmid=28387823 | doi=10.1093/neuros/nyx091 | pmc=5808153 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28387823  }} </ref>
CCM can also be subdivided into two, according to its pattern of occurrence: <ref name="pmid28387823">{{cite journal| author=Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B | display-authors=etal| title=Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. | journal=Neurosurgery | year= 2017 | volume= 80 | issue= 5 | pages= 665-680 | pmid=28387823 | doi=10.1093/neuros/nyx091 | pmc=5808153 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28387823  }} </ref>


*Familial or Hereditary CCM
*[[Familial]] or [[Hereditary]] CCM
**constitutes 20% of all cavernous angioma cases
**constitutes 20% of all [[cavernous angioma]] cases
**occurs as multiple lesions
**occurs as multiple lesions
**can have frameshift, nonsense or splice-site mutations
**can have [[frameshift]], [[nonsense]] or [[splice-site mutations]]
**can also have deletions or duplication of exons <ref name="pmid28387823">{{cite journal| author=Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B | display-authors=etal| title=Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. | journal=Neurosurgery | year= 2017 | volume= 80 | issue= 5 | pages= 665-680 | pmid=28387823 | doi=10.1093/neuros/nyx091 | pmc=5808153 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28387823  }} </ref>
**can also have [[deletions]] or [[duplication]] of [[exons]] <ref name="pmid28387823">{{cite journal| author=Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B | display-authors=etal| title=Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. | journal=Neurosurgery | year= 2017 | volume= 80 | issue= 5 | pages= 665-680 | pmid=28387823 | doi=10.1093/neuros/nyx091 | pmc=5808153 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28387823  }} </ref>


*Sporadic CCM
*[[Sporadic]] CCM
**occurs as single lesions <ref name="pmid22133177">{{cite journal| author=Dalyai RT, Ghobrial G, Awad I, Tjoumakaris S, Gonzalez LF, Dumont AS | display-authors=etal| title=Management of incidental cavernous malformations: a review. | journal=Neurosurg Focus | year= 2011 | volume= 31 | issue= 6 | pages= E5 | pmid=22133177 | doi=10.3171/2011.9.FOCUS11211 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22133177  }} </ref>
**occurs as single lesions <ref name="pmid22133177">{{cite journal| author=Dalyai RT, Ghobrial G, Awad I, Tjoumakaris S, Gonzalez LF, Dumont AS | display-authors=etal| title=Management of incidental cavernous malformations: a review. | journal=Neurosurg Focus | year= 2011 | volume= 31 | issue= 6 | pages= E5 | pmid=22133177 | doi=10.3171/2011.9.FOCUS11211 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22133177  }} </ref>



Revision as of 10:41, 11 March 2022

Cavernous angioma pathophysiology
MRI: Cavernous malformation.
(Image courtesy of RadsWiki)

Cavernous angioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cavernous angioma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

CT

MRI

MRA

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cavernous angioma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cavernous angioma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cavernous angioma pathophysiology

CDC on Cavernous angioma pathophysiology

Cavernous angioma pathophysiology in the news

Blogs on Cavernous angioma pathophysiology

Directions to Hospitals Treating Cavernous angioma

Risk calculators and risk factors for Cavernous angioma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D, M.D.


Overview

Developmental venous anomaly (DVA) can cause a chronic increase in intracranial pressure which can form microhemorrhages around DVA, leading to the development and growth of cavernous angioma. There are two patterns of cavernous angioma, the sporadic and the familial pattern.

Pathophysiology

In up to 30% there is a coincidence of cerebral cavernous malformation (CCM0 with a venous angioma, also known as a developmental venous anomaly (DVA). These lesions appear either as enhancing linear blood vessels or caput medusae, a radial orientation of small vessels that resemble the hair of Medusa from Greek mythology. These lesions are thought to represent developmental anomalies of normal venous drainage. These lesions should not be removed, as reports of venous infarcts have been reported. When found in association with a CCM that needs resection, great care should be taken not to disrupt the angioma.

Left Orbital Cavernous Hemangioma

Frontal and temporal lobes are the most common sites of occurrence, and 80-90% of the lesions are supratentorial.

CCM can also be subdivided into two, according to its pattern of occurrence: [1]

Genetics

Genes involved in the pathogenesis of cavernous angioma include: [3][4][5]


Cavernous Angioma Familial Genes [5]
Gene Gene Locus Chromosome Location Function
CCM1 KRIT1 7q regulation of angiogenesis
CCM2 CCM2 7p regulation of angiogenesis, maintenance of vessel integrity, and stabilization of endothelial cell junction
CCM3 PDCD10 3q stimulation of cell proliferation, regulation of apoptosis, regulation of heart development, angiogenesis, vasculogenesis and hematopoiesis


General Pathology

  • Cavernous angioma is diagnosed using clinical imaging.

Microscopic Pathology

  • Key feature: Absence of muscular layer in the vessel wall.
Microscopic pathology of cavernous angioma. Source:LibrePathology

References

  1. 1.0 1.1 Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B; et al. (2017). "Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel". Neurosurgery. 80 (5): 665–680. doi:10.1093/neuros/nyx091. PMC 5808153. PMID 28387823.
  2. Dalyai RT, Ghobrial G, Awad I, Tjoumakaris S, Gonzalez LF, Dumont AS; et al. (2011). "Management of incidental cavernous malformations: a review". Neurosurg Focus. 31 (6): E5. doi:10.3171/2011.9.FOCUS11211. PMID 22133177.
  3. Choquet H, Pawlikowska L, Lawton MT, Kim H (2015). "Genetics of cerebral cavernous malformations: current status and future prospects". J Neurosurg Sci. 59 (3): 211–20. PMC 4461471. PMID 25900426.
  4. Kim J (2016). "Introduction to cerebral cavernous malformation: a brief review". BMB Rep. 49 (5): 255–62. doi:10.5483/bmbrep.2016.49.5.036. PMC 5070704. PMID 26923303.
  5. 5.0 5.1 Zafar A, Quadri SA, Farooqui M, Ikram A, Robinson M, Hart BL; et al. (2019). "Familial Cerebral Cavernous Malformations". Stroke. 50 (5): 1294–1301. doi:10.1161/STROKEAHA.118.022314. PMC 6924279 Check |pmc= value (help). PMID 30909834.